Concepedia

Yoshimichi Tanaka

YT

27

Publications

1K

Citations

18

H-Index

2005

Active since

Affiliations

Osaka Medical and Pharmaceutical University(Current)

Osaka International Cancer Institute

Yoshimichi Tanaka is an author at Osaka Medical and Pharmaceutical University specializing in medicine, oncology, and obstetrics.

Top concepts

Publications per year

2005–2021

27

Publications

27

The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer

Masaaki Takai, Yoshito Terai, Hiroshi Kawaguchi et al. · Journal of Ovarian Research · 2014 · 107 citations · Full text

Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer

Yoshimichi Tanaka, Yoshito Terai, Hiroshi Kawaguchi et al. · Cancer Biology & Therapy · 2013 · 106 citations · Full text

CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways

Kiyoko Nakamura, Yoshito Terai, Akiko Tanabe et al. · Oncology Reports · 2017 · 102 citations · Full text

, , +16

Maintenance Treatment with Bevacizumab Prolongs Survival in an<i>In vivo</i>Ovarian Cancer Model

Seiji Mabuchi, Yoshito Terai, Kenichiro Morishige et al. · Clinical Cancer Research · 2008 · 94 citations · Full text

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

Satoe Fujiwara, Yoshito Terai, Hiroshi Kawaguchi et al. · Journal of Ovarian Research · 2012 · 78 citations · Full text

Rows per page

1–5 of 27